UP!
| Period | Date | Adjusted Actuals EPS | GAAP EPS |
|---|---|---|---|
| Q1 2021 | 2022-05-04 | Future report Set alerts | |
| Q4 2020 | 2022-03-01 | -0.04 | -0.04 |
| Q3 2020 | 2021-11-09 | -0.07 | -0.07 |
| Q2 2020 | 2021-08-09 | 0.03 | 0.03 |
| Q1 2020 | 2021-05-06 | 0.00 | 0.00 |
| Q4 2019 | 2021-02-26 | -0.48 | -0.48 |
| Q3 2019 | 2019-11-08 | -0.19 | -0.19 |
| Q2 2019 | 2019-08-08 | -0.13 | -0.13 |
| Q1 2019 | 2019-05-10 | -0.09 | -0.10 |
| Q4 2018 | 2019-02-19 | -1.92 | -1.93 |
| 2016-05-14 | Reiterated Rating | HC Wainwright | Buy | |
| 2016-05-13 | Reiterated Rating | Brean Capital | Buy | $28.00 |
| 2016-03-29 | Reiterated Rating | Brean Capital | Buy | $28.00 |
| 2015-11-24 | Reiterated Rating | HC Wainwright | Buy | $14.00 |
| 2015-10-27 | Reiterated Rating | Brean Capital | Buy | $28.00 |
| 2015-09-02 | Initiated Coverage | HC Wainwright | Buy | $19.00 |
| 2015-08-17 | Reiterated Rating | Brean Capital | Buy | $28.00 |
| 2015-07-27 | Reiterated Rating | Brean Capital | Buy | |
| 2015-07-17 | Initiated Coverage | Brean Capital | Buy | $28.00 |
| 2015-06-18 | Boost Price Target | Brean Capital | Buy | $26.00 to $28.00 |
| 2015-04-14 | Set Price Target | Brean Capital | Buy | $26.00 |
| 2015-04-14 | Boost Price Target | MLV & Co. | Buy | $12.00 to $22.00 |
| 2015-03-10 | Reiterated Rating | Brean Capital | Buy | $26.00 |
| 2014-12-09 | Downgrade | Aegis | Buy to Hold | |
| 2014-09-05 | Lower Price Target | Aegis | $40.00 to $38.00 | |
| 2014-06-12 | Initiated | Aegis Capital | Buy | $40 |
| 2014-06-12 | Initiated Coverage | Aegis | Buy | $40.00 |
| 2014-03-19 | Initiated Coverage | Brean Capital | Buy | $26.00 |
| 2016-05-14 | Reiterated Rating | HC Wainwright | Buy | |
| 2016-05-13 | Reiterated Rating | Brean Capital | Buy | $28.00 |
| 2016-03-29 | Reiterated Rating | Brean Capital | Buy | $28.00 |
| 2015-11-24 | Reiterated Rating | HC Wainwright | Buy | $14.00 |
| 2015-10-27 | Reiterated Rating | Brean Capital | Buy | $28.00 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In REPH 45 funds of 2213 total. Show all
| Fund name | Ticker shares |
|---|---|
| AWM Investment Company, Inc. | 5.61M |
| Vanguard Group, Inc | 1.68M |
| Alyeska Investment Group, L.P. | 1.07M |
| STEPHENS INC /AR/ | 1.04M |
| First Eagle Investment Management, LLC | 1.02M |
| RENAISSANCE TECHNOLOGIES LLC | 0.96M |
| Broadfin Capital, LLC | 0.72M |
| KORNITZER CAPITAL MANAGEMENT INC /KS | 0.69M |
| Concept Capital Markets, LLC | 0.47M |
| BlackRock Inc. | 0.40M |
| GEODE CAPITAL MANAGEMENT, LLC | 0.37M |
| BRIDGEWAY CAPITAL MANAGEMENT INC | 0.25M |
| Clear Harbor Asset Management, LLC | 0.24M |
| BlackRock Institutional Trust Company, N.A. | 0.22M |
| CITADEL ADVISORS LLC | 0.14M |
| Name Relationship | Total Shares | Holding stocks |
|---|---|---|
| Broadfin Healthcare Master Fund Ltd | 29.01% (2236025) | AEGR / FLML / MELA / MRTX / PETX / PGNX / QLTI / REPH / |
| SCP Vitalife Partners II LP | 28.19% (2172900) | REPH / RWLK / |
| Stonepine Capital Management, LLC | 24.68% (1902380) | REPH / VIVE / |
| Flynn James E Possible Member of 10% Group | 15.27% (1176685) | AAVL / ALIM / ASPX / ATRS / AUXL / AXGN / CASM / CYCC / DRNA / EHTH / EMAG / FIXX / HITK / LOXO / NURO / PRTO / REPH / RIGL / STRM / TRGT / TWTI / VNDA / XNPT / |
| LUDOMIRSKI ABRAHAM | 10.10% (778634) | REPH / VSH / |
| CHURCHILL WINSTON J | 10.10% (778634) | AMKR / GRIF / ISSC / REPH / |
| SCP Vitalife Partners (Israel) II, L.P. | 9.42% (726055) | REPH / RWLK / |
| HENWOOD GERALDINE President and CEO | 2.33% (179231) | ALKS / REPH / TTPH / |
| Mack Randall Senior VP, Development | 0.44% (33752) | REPH / |
| McCallum Stewart Chief Medical Officer | 0.41% (31841) | REPH / |
| Celano Michael Chief Financial Officer | 0.37% (28475) | OSUR / REPH / |
| Graff Fred Chief Commercial Officer | 0.35% (27083) | REPH / |
| Myers Diane Senior VP-Reg./Quality | 0.24% (18528) | REPH / |
| Lake Ryan David Senior VP, Finance & CAO | 0.15% (11500) | REPH / |
| Mattila Jyrki Executive VP, Business Dev. | 0.15% (11500) | BSTC / LPCN / REPH / |
| Weisman Wayne | 0.09% (7000) | REPH / RWLK / |
| Garner Charles CFO and Chief Business Officer | 0.06% (5000) | REPH / |
| Nichols Donna CAO/Controller | 0.06% (4840) | REPH / |
| ALTOMARI ALFRED | 0.02% (1500) | AGRX / INSM / REPH / |
| Flynn Karen | 0.01% (800) | REPH / WST / |
UM